Menu

Informed Consent

In some states* existing laws require healthcare providers (HCPs) to obtain informed consent for genetic tests. Due to changing state laws and regulations, it is the HCP’s responsibility to verify whether they practice in a state where informed consent is required prior to ordering genetic testing. If the HCP does practice in a state where informed consent is required, there is a section on the Test Request Form (TRF) labeled Healthcare Provider’s Signature where a signature is required to begin test processing. A copy of an Informed Consent Form is available below (also included in the test kit). Please contact your Myriad Customer Service Specialist at 800-469-7423 for additional information.

  • Informed Consent for Hereditary Cancer Genetic Testing - Describes the benefits, risks, and limitations of genetic testing for inherited susceptibility to cancer. En Español
  • Informed Consent for Prolaris® - Describes the benefits and limitations of Prolaris testing to determine risk for prostate cancer disease progression.
  • Informed Consent For TheraGuide® - Describes the benefits, risks, and limitations of genetic testing to determine risk for developing toxicity to the family of drugs related to 5-fluorouracil (5-FU).
  • *These states include, but are not limited to, Alaska, New Mexico, Massachusetts, South Carolina, New York, Arizona and Florida.

     

BRACAnalysis, COLARIS, COLARIS AP, MELARIS, Myriad myPath, myPlan, myRisk, TheraGuide, PREZEON, PANEXIA, and Prolaris are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions